Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Ruof

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
The Journal of Rheumatology|May 6, 1999
Comparison of the Dougados Functional Index and the Bath Ankylosing Spondylitis Functional Index. A literature reviewJ Ruof, G Stucki
The Journal of Rheumatology|May 6, 1999
Validity aspects of erythrocyte sedimentation rate and C-reactive protein in ankylosing spondylitis: a literature reviewJ Ruof, G Stucki
Zeitschrift Fur Rheumatologie|December 29, 1998
[Cost-effectiveness--limits between optimization and rationing]J Ruof, O Schöffski
Zeitschrift Fur Rheumatologie|December 20, 2002
[Current aspects of cost effectiveness of TNF-alpha blocking agents in patients with rheumatoid arthritis]Sonja Merkesdal, J Ruof
Zeitschrift Fur Rheumatologie|June 27, 2000
[Cyclooxygenase-2 (Cox-2) selective inhibitors: socioeconomic and pharmaco-epidemiologic aspects]J Ruof, J L Hülsemann
Zeitschrift Fur Rheumatologie|September 29, 1999
Evaluation of a German version of the Bath Ankylosing Spondylitis Functional Index (BASFI) and Dougados Functional Index (D-FI)J Ruof, O Sangha, G Stucki
The Journal of Rheumatology|September 24, 1999
Comparative responsiveness of 3 functional indices in ankylosing spondylitisJ Ruof, O Sangha, G Stucki
Current Opinion in Rheumatology|May 13, 1999
Evaluation of costs in rheumatic diseases: a literature reviewJ Ruof, J L Hülsemann, G Stucki
Rheumatology (Oxford, England)|July 13, 1999
Development and validation of a self-administered systemic sclerosis questionnaire (SySQ)J Ruof, P Brühlmann, B A Michel, et al.
Health Economics Review|December 19, 2019
Different interpretation of additional evidence for HTA by the commissioned HTA body and the commissioning decision maker in Germany: whenever IQWiG and Federal Joint Committee disagreeC M Dintsios, F Worm, J Ruof, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
The Journal of Rheumatology|May 6, 1999
Comparison of the Dougados Functional Index and the Bath Ankylosing Spondylitis Functional Index. A literature reviewJ Ruof, G Stucki
The Journal of Rheumatology|May 6, 1999
Validity aspects of erythrocyte sedimentation rate and C-reactive protein in ankylosing spondylitis: a literature reviewJ Ruof, G Stucki
Zeitschrift Fur Rheumatologie|December 29, 1998
[Cost-effectiveness--limits between optimization and rationing]J Ruof, O Schöffski
Zeitschrift Fur Rheumatologie|December 20, 2002
[Current aspects of cost effectiveness of TNF-alpha blocking agents in patients with rheumatoid arthritis]Sonja Merkesdal, J Ruof
Zeitschrift Fur Rheumatologie|June 27, 2000
[Cyclooxygenase-2 (Cox-2) selective inhibitors: socioeconomic and pharmaco-epidemiologic aspects]J Ruof, J L Hülsemann
Zeitschrift Fur Rheumatologie|September 29, 1999
Evaluation of a German version of the Bath Ankylosing Spondylitis Functional Index (BASFI) and Dougados Functional Index (D-FI)J Ruof, O Sangha, G Stucki
The Journal of Rheumatology|September 24, 1999
Comparative responsiveness of 3 functional indices in ankylosing spondylitisJ Ruof, O Sangha, G Stucki
Current Opinion in Rheumatology|May 13, 1999
Evaluation of costs in rheumatic diseases: a literature reviewJ Ruof, J L Hülsemann, G Stucki
Rheumatology (Oxford, England)|July 13, 1999
Development and validation of a self-administered systemic sclerosis questionnaire (SySQ)J Ruof, P Brühlmann, B A Michel, et al.
Health Economics Review|December 19, 2019
Different interpretation of additional evidence for HTA by the commissioned HTA body and the commissioning decision maker in Germany: whenever IQWiG and Federal Joint Committee disagreeC M Dintsios, F Worm, J Ruof, et al.
Pageof 3